Core Viewpoint - The announcement details a share reduction plan by a major shareholder of Guangzhou Jiete Biological Filtration Co., Ltd., indicating a planned sale of shares due to personal financial needs, while ensuring that this action will not affect the company's control or governance structure [2][3][7]. Group 1: Shareholder Information - The shareholder, Guangzhou Luogang District Huizi Investment Management Partnership (Limited Partnership), holds 1,396,950 shares, representing 1.00% of the company's total equity [2]. - The shares were acquired prior to the company's IPO and became tradable on January 30, 2023, after the lifting of restrictions [2]. Group 2: Reduction Plan Details - The shareholder plans to reduce their holdings by up to 186,315 shares, which is approximately 0.1327% of the total equity, within a three-month period starting from July 2, 2025, to October 1, 2025 [3]. - The reduction will be executed through centralized bidding, and any changes in the company's share structure during this period will lead to adjustments in the reduction plan [3]. Group 3: Control and Governance Impact - The reduction plan will not lead to a change in the company's control, as the shareholder is an associated party of the controlling shareholder, ensuring that governance and operational continuity remain unaffected [3][7]. - The actual controller's family member, Wang Jing, will not reduce her indirect holdings through the investment partnership, further stabilizing the control structure [3][7]. Group 4: Previous Commitments - The shareholder has previously committed not to transfer or manage shares held prior to the IPO for a period of 12 months post-listing, which aligns with the current reduction plan [5][6]. - Wang Jing has also made commitments regarding the management of her shares, including restrictions on transfer during specific periods [6].

证券代码：688026 证券简称：洁特生物 公告编号：2025-010 转债代码：118010 转债简称：洁特转债 广州洁特生物过滤股份有限公司 第四届董事会第十七次会议决议公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 广州洁特生物过滤股份有限公司（以下简称"公司"）第四届董事会第十七次会议于2025年4月11日以现 场及通讯相结合方式召开，会议通知已于2025年4月3日通过通讯方式送达全体董事。本次会议由董事长 袁建华先生召集并主持，应参加董事7人，实际参加表决董事7人。本次会议的召集、召开和表决程序均 符合国家有关法律、法规及《公司章程》等有关规定。经全体董事一致同意，形成决议如下： 一、以4票同意，0票反对，0票弃权，审议通过了《关于不向下修正"洁特转债"转股价格的议案》，关 联董事袁建华、Yuan Ye James、Dannie Yuan回避表决。 董事会同意本次不向下修正转股价格，同时在未来三个月内（即日起至2025年7月11日）如再次触发可 转换公司债券转股价格向下修正条款的，亦不提出向下修正方案。在此期 ...